Praram 9 Hospital PCL (BKK:PR9)
Thailand · Delayed Price · Currency is THB 16.30
+0.10 (0.62%)
Jun 12, 2026, 4:36 PM ICT
Praram 9 Hospital PCL Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 5,338 | 5,292 | 4,649 | 4,216 | 4,122 | 3,000 |
Other Revenue | 54.64 | 49.14 | 41.51 | 36.86 | 28.16 | 26.12 |
| 5,393 | 5,341 | 4,691 | 4,253 | 4,150 | 3,026 | |
Revenue Growth (YoY) | 10.93% | 13.88% | 10.29% | 2.47% | 37.16% | 14.93% |
Cost of Revenue | 3,393 | 3,346 | 3,045 | 2,820 | 2,724 | 2,172 |
Gross Profit | 2,000 | 1,995 | 1,645 | 1,433 | 1,427 | 853.75 |
Selling, General & Admin | 1,054 | 1,032 | 837.22 | 773.68 | 735.1 | 557.21 |
Operating Expenses | 1,054 | 1,032 | 837.22 | 773.68 | 735.1 | 557.21 |
Operating Income | 946.13 | 962.67 | 807.89 | 659.09 | 691.81 | 296.53 |
Interest Expense | -0.97 | -0.76 | -0.49 | -0.64 | -0.48 | -0.48 |
Interest & Investment Income | 46.65 | 51.32 | 54.62 | 30.17 | 8.72 | 4.21 |
Pretax Income | 991.82 | 1,013 | 862.01 | 688.63 | 700.05 | 300.27 |
Income Tax Expense | 185.05 | 190.51 | 149.33 | 130.77 | 132.44 | 51.1 |
Net Income | 806.77 | 822.71 | 712.68 | 557.86 | 567.61 | 249.17 |
Net Income to Common | 806.77 | 822.71 | 712.68 | 557.86 | 567.61 | 249.17 |
Net Income Growth | 6.98% | 15.44% | 27.75% | -1.72% | 127.80% | 23.32% |
Shares Outstanding (Basic) | 786 | 786 | 786 | 786 | 786 | 786 |
Shares Outstanding (Diluted) | 786 | 786 | 786 | 786 | 786 | 786 |
EPS (Basic) | 1.03 | 1.05 | 0.91 | 0.71 | 0.72 | 0.32 |
EPS (Diluted) | 1.03 | 1.05 | 0.91 | 0.71 | 0.72 | 0.32 |
EPS Growth | 6.98% | 15.44% | 27.75% | -1.72% | 127.80% | 23.32% |
Free Cash Flow | 384.36 | 495.95 | 804.87 | 514.74 | 736.32 | 344.49 |
Free Cash Flow Per Share | 0.49 | 0.63 | 1.02 | 0.66 | 0.94 | 0.44 |
Dividend Per Share | 0.500 | 0.500 | 0.400 | 0.300 | 0.290 | 0.140 |
Dividend Growth | 25.00% | 25.00% | 33.33% | 3.45% | 107.14% | 27.27% |
Gross Margin | 37.08% | 37.35% | 35.07% | 33.69% | 34.38% | 28.21% |
Operating Margin | 17.54% | 18.02% | 17.22% | 15.50% | 16.67% | 9.80% |
Profit Margin | 14.96% | 15.40% | 15.19% | 13.12% | 13.68% | 8.23% |
Free Cash Flow Margin | 7.13% | 9.29% | 17.16% | 12.10% | 17.74% | 11.39% |
EBITDA | 1,255 | 1,263 | 1,097 | 941.45 | 974.8 | 570.13 |
EBITDA Margin | 23.28% | 23.65% | 23.39% | 22.14% | 23.49% | 18.84% |
D&A For EBITDA | 308.99 | 300.57 | 289.25 | 282.35 | 282.98 | 273.6 |
EBIT | 946.13 | 962.67 | 807.89 | 659.09 | 691.81 | 296.53 |
EBIT Margin | 17.54% | 18.02% | 17.22% | 15.50% | 16.67% | 9.80% |
Effective Tax Rate | 18.66% | 18.80% | 17.32% | 18.99% | 18.92% | 17.02% |
Revenue as Reported | 5,393 | 5,341 | 4,691 | 4,253 | 4,150 | 3,026 |